Global Corporate Controller

About Sequel  Sequel, headquartered in Manchester, New Hampshire, is a company developing the next generation of transformative drug-delivery advancements starting with diabetes. Sequel’s approach is to look at diabetes management holistically to advance systems that make living with diabetes simpler and easier for all. Sequel’s flagship product, the twiist Automated Insulin Delivery (AID) System, launched in July 2025 for people with type 1 diabetes providing them with personalized diabetes management.     Job Overview  Reporting to the Chief Financial Officer, the Controller will lead the company’s accounting operations during a period of rapid growth and increasing complexity. This role is responsible for ensuring accurate financial reporting, strong internal controls, and scalable processes in a commercial, product‑based organization as Sequel prepares for a future initial public offering.